Epidemiology of sympathetic nervous system tumors in the childhood population in Sergipe: an 18-years analysis
DOI:
https://doi.org/10.33448/rsd-v10i11.20013Keywords:
Neoplasm; Epidemiology; Neuroblastoma; Child; Adolescent.Abstract
Objective: To describe the epidemiology of Sympathetic Nervous System Tumors in the State of Sergipe over 18 years. Methods: This is a cross-sectional, retrospective, quantitative study. Data were collected from the Population-Based Cancer Registry of the Pediatric Oncology Center located at the Sergipe State Reference Hospital. All patients aged between 0 and 19 years listed in the RCBP from 1996 to 2014 were included. Results: In Sergipe, between 1996 and 2014, 1705 cases of Childhood Cancer were registered, of which 45 (2.6%) were tumors of the Sympathetic Nervous System. There was a predominance of male patients (53.3%) and the most affected group were those under 5 years old (71.1%). An annual percentage growth rate of 0.08% over this period was observed. Conclusion: It was noticed that the incidence of TSNS is still low compared to other states in Brazil and other countries with more resources, which can highlight the importance of improving the diagnosis of tumors of the sympathetic nervous system in Sergipe.
References
Ahmed, A. A., Zhang, L., Reddivalla, N., & Hetherington, M. (2017). Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors. Pediatric hematology and oncology, 34(3), 165-185.
Alvi, S., Karadaghy, O., Manalang, M., & Weatherly, R. (2017). Clinical manifestations of neuroblastoma with head and neck involvement in children. International journal of pediatric otorhinolaryngology, 97, 157-162.
Amano, H., Uchida, H., Tanaka, Y., Tainaka, T., Mori, M., Oguma, E., & Koh, K. (2018). Excellent prognosis of patients with intermediate-risk neuroblastoma and residual tumor postchemotherapy. Journal of pediatric surgery, 53(9), 1761-1765.
Barros Rodrigues, M., Chong-Silva, D. C., & Neto, H. J. C (2021). Guia Prático para Produção e Submissão de Artigos Científicos.
Behera, G., Chhabra, G., Mishra, P., & Sable, M. (2020). Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology. Diagnostic cytopathology, 48(5), 464-474.
Brisse, H. J., Blanc, T., Schleiermacher, G., Mosseri, V., Philippe-Chomette, P., Janoueix-Lerosey, I., ... & Sarnacki, S. (2017). Radiogenomics of neuroblastomas: relationships between imaging phenotypes, tumor genomic profile and survival. PloS one, 12(9),
e0185190.
Burnand, K., Barone, G., McHugh, K., & Cross, K. (2019). Preoperative computed tomography scanning for abdominal neuroblastomas is superior to magnetic resonance imaging for safe surgical planning. Pediatric blood & cancer, 66(11), e27955.
Camargo, B., de Oliveira Santos, M., Rebelo, M. S., de Souza Reis, R., Ferman, S., Noronha, C. P., & Pombo‐de‐Oliveira, M. S. (2010). Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries. International journal of cancer, 126(3), 715-720.
Chang, H. H., Liu, Y. L., Lu, M. Y., Jou, S. T., Yang, Y. L., Lin, D. T., ... & Hsu, W. M. (2017). A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients. Oncotarget, 8(3), 4360.
Coughlan, D., Gianferante, M., Lynch, C. F., Stevens, J. L., & Harlan, L. C. (2017). Treatment and survival of childhood neuroblastoma: evidence from a population-based study in the United States. Pediatric hematology and oncology, 34(5), 320-330.
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa. Editora Artes Médicas.
Heck, J. E., Lee, P. C., Wu, C. K., Tsai, H. Y., Ritz, B., Arah, O. A., & Li, C. Y. (2020). Gestational risk factors and childhood cancers: A cohort study in Taiwan. International journal of cancer, 147(5), 1343-1353.
INCA. Instituto Nacional de Câncer (2008). Câncer na criança e no adolescente no Brasil: dados dos registros de base populacional e de mortalidade.
Liu, Q., Feng, L., Xue, H., Su, W., & Li, G. (2020). Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma. Medicine, 99(10).
Lucena, J. N., Alves, M. T. S., Abib, S. C. V., Souza, G. O. D., Neves, R. P. D. C., & Caran, E. M. M. (2018). Clinical and epidemiological characteristics and survival outcomes of children with neuroblastoma: 21 years of experience at the Instituto de Oncologia Pediátrica, in São Paulo, Brazil. Revista Paulista de Pediatria, 36, 254-260.
Maris, J. M. (2010). Recent advances in neuroblastoma. New England Journal of Medicine, 362(23), 2202-2211.
Nakagawara, A., Li, Y., Izumi, H., Muramori, K., Inada, H., & Nishi, M. (2018). Neuroblastoma. Japanese journal of clinical oncology, 48(3), 214–241. https://doi.org/10.1093/jjco/hyx176.
Santos Júnior, C. J., Romão, C. M. D. S. B., Alves, M. J. R. G., Batinga, A. M. C. S., da Silva Gomes, V. M., Araújo, N. S., & Leite, L. A. C. (2018). Características clínico-epidemiológicas do câncer infantojuvenil no estado de Alagoas, Brasil. Revista de Medicina, 97(5), 454-460.
Su, Y., Wang, L., Wang, X., Yue, Z., Xing, T., Zhao, W., ... & Ma, X. (2019). Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma. Cancer medicine, 8(4), 1558-1566.
Shuangshoti, S., Shuangshoti, S., Nuchprayoon, I., Kanjanapongkul, S., Marrano, P., Irwin, M. S., & Thorner, P. S. (2012). Natural course of low risk neuroblastoma. Pediatric blood & cancer, 58(5), 690-694.
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014). Childhood and adolescent cancer statistics, 2014. CA: a cancer journal for clinicians, 64(2), 83-103.
Yang, C. L., Serra-Roma, A., Gualandi, M., Bodmer, N., Niggli, F., Schulte, J. H., ... & Shakhova, O. (2020). Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity. Oncotarget, 11(24), 2357.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Milenna Guimarães Lima; Ana Jovina Barreto Bispo ; Mariana Aragão Passos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
